OC
RNA

Oppenheimer & Co’s PROSENSA HLDGS N V ORD SHS (NLD) RNA Stock Holding History

Oppenheimer & Co’s Portfolio RNA Stock Details RNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-10,000
Closed -$84K – 1553
2014
Q3 		$84K Buy
+10,000
New +$94.8K ﹤0.01% 1357
2014
Q2 		– Sell
-21,000
Closed -$118K – 1536
2014
Q1 		$118K Buy
+21,000
New +$130K ﹤0.01% 1323

Other funds holding RNA

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VLKIM
Van Lanschot Kempen Investment Management Amsterdam, Netherlands $11.4B AUM 16.77% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
CPM
Chesapeake Partners Management Baltimore, Maryland $669M AUM 1.23% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
PCM
Proxima Capital Management New York $21M AUM 3.49% 1-Year Est. Return

Oppenheimer & Co's RNA Position: Q4 2014 in Review

Oppenheimer & Co sold out of PROSENSA HLDGS N V ORD SHS (NLD) (RNA) in Q4 2014, closing a stake of 10,000 shares — an estimated $84K sold.

Oppenheimer & Co first reported a position in RNA in Q1 2014 and held it in 2 quarters. The position peaked at $118K in Q1 2014. 47 funds tracked by Wall St. Rank hold RNA as of Q4 2014.

  • Oppenheimer & Co reported no remaining PROSENSA HLDGS N V ORD SHS (NLD) position as of Q4 2014 after selling out during the quarter.
  • Oppenheimer & Co sold 10,000 PROSENSA HLDGS N V ORD SHS (NLD) shares in Q4 2014, an estimated $84K.
  • Oppenheimer & Co first reported a position in PROSENSA HLDGS N V ORD SHS (NLD) in Q1 2014 and held it in 2 quarters.
  • Oppenheimer & Co's PROSENSA HLDGS N V ORD SHS (NLD) position peaked at $118K in Q1 2014.
  • 47 funds tracked by Wall St. Rank held PROSENSA HLDGS N V ORD SHS (NLD) as of Q4 2014.

Based on Oppenheimer & Co's 13F filing for Q4 2014, filed 10 Feb 2015.